scispace - formally typeset
K

Kimiyo Raymond

Researcher at Mayo Clinic

Publications -  95
Citations -  3114

Kimiyo Raymond is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Congenital disorder of glycosylation & Glycosylation. The author has an hindex of 28, co-authored 85 publications receiving 2420 citations. Previous affiliations of Kimiyo Raymond include University of Rochester & Yale University.

Papers
More filters
Journal ArticleDOI

Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: A worldwide collaborative project

David M.S. McHugh, +245 more
- 01 Mar 2011 - 
TL;DR: An unprecedented level of cooperation and collaboration has allowed the objective definition of cutoff target ranges for 114 markers to be applied to newborn screening of rare metabolic disorders.
Journal ArticleDOI

Multiple Phenotypes in Phosphoglucomutase 1 Deficiency

TL;DR: In this paper, the authors evaluated patients who had a novel recessive disorder of glycosylation, with a range of clinical manifestations that included hepatopathy, bifid uvula, malignant hyperthermia, hypogonadotropic hypogono-morphosis, growth retardation, hypoglycemia, myopathy, dilated cardiomyopathy, and cardiac arrest.
Journal ArticleDOI

PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia.

TL;DR: PGM3-CDG is defined as a treatable immunodeficiency, the power of whole-exome sequencing in gene discoveries for rare disorders is documented, and the utility of genomic analyses in studying combined and variable phenotypes is illustrated.
Journal ArticleDOI

Combined newborn screening for succinylacetone, amino acids, and acylcarnitines in dried blood spots.

TL;DR: The inclusion of SUAC analysis into routine analysis of AC and AA allows for rapid and cost-effective screening for TYR 1 with no tangible risk of false-negative results.
Journal ArticleDOI

Determination of Total Homocysteine, Methylmalonic Acid, and 2-Methylcitric Acid in Dried Blood Spots by Tandem Mass Spectrometry

TL;DR: Application of this assay reduced the false-positive rate and improved the positive predictive value of NBS for conditions associated with abnormal propionylcarnitine and methionine concentrations.